1.08
Schlusskurs vom Vortag:
$1.105
Offen:
$1.1
24-Stunden-Volumen:
12,118
Relative Volume:
0.33
Marktkapitalisierung:
$12.50M
Einnahmen:
$996.00K
Nettoeinkommen (Verlust:
$-6.09M
KGV:
-2.0377
EPS:
-0.53
Netto-Cashflow:
$-9.76M
1W Leistung:
-3.57%
1M Leistung:
-1.82%
6M Leistung:
+24.14%
1J Leistung:
-38.53%
Therapeuticsmd Inc Stock (TXMD) Company Profile
Firmenname
Therapeuticsmd Inc
Sektor
Telefon
561-961-1900
Adresse
951 YAMATO ROAD, SUITE 220, BOCA RATON, FL
Vergleichen Sie TXMD mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
TXMD
Therapeuticsmd Inc
|
1.08 | 12.27M | 996.00K | -6.09M | -9.76M | -0.53 |
![]()
ZTS
Zoetis Inc
|
153.20 | 67.75B | 9.39B | 2.62B | 2.22B | 5.81 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
15.29 | 47.88B | 29.96B | 957.25M | 4.77B | 0.304 |
![]()
HLN
Haleon Plc Adr
|
9.84 | 43.70B | 14.26B | 1.98B | 2.47B | 0.4347 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.48 | 21.51B | 16.70B | -157.13M | 1.19B | -0.155 |
![]()
UTHR
United Therapeutics Corp
|
380.47 | 18.31B | 2.99B | 1.21B | 1.13B | 25.06 |
Therapeuticsmd Inc Stock (TXMD) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2020-08-07 | Herabstufung | Jefferies | Hold → Underperform |
2020-05-19 | Herabstufung | JP Morgan | Overweight → Neutral |
2019-12-02 | Eingeleitet | Guggenheim | Buy |
2019-10-17 | Eingeleitet | H.C. Wainwright | Buy |
2019-04-30 | Fortgesetzt | Noble Capital Markets | Outperform |
2018-06-15 | Eingeleitet | JP Morgan | Overweight |
2017-09-08 | Eingeleitet | Morgan Stanley | Equal-Weight |
2017-07-11 | Hochstufung | Oppenheimer | Perform → Outperform |
2017-05-09 | Herabstufung | Oppenheimer | Outperform → Perform |
2016-11-22 | Fortgesetzt | Jefferies | Buy |
2016-11-22 | Eingeleitet | Oppenheimer | Outperform |
2016-11-07 | Fortgesetzt | Guggenheim | Buy |
2016-04-04 | Eingeleitet | Goldman | Buy |
2015-12-08 | Bestätigt | Jefferies | Buy |
2015-12-08 | Bestätigt | Stifel | Buy |
2015-09-21 | Bestätigt | Jefferies | Buy |
2015-06-09 | Eingeleitet | Guggenheim | Buy |
2014-07-08 | Eingeleitet | FBR Capital | Outperform |
2014-04-17 | Bestätigt | Noble Financial | Buy |
2014-01-28 | Bestätigt | Noble Financial | Buy |
Alle ansehen
Therapeuticsmd Inc Aktie (TXMD) Neueste Nachrichten
How to build a custom watchlist for TherapeuticsMD Inc.Trade Analysis Report & Verified Chart Pattern Trade Signals - Newser
What technical models suggest about TherapeuticsMD Inc.’s comebackWall Street Watch & Weekly Top Stock Performers List - Newser
TherapeuticsMD Inc. stock volume spike explainedMarket Movers & Fast Entry Momentum Trade Alerts - Newser
Has TherapeuticsMD Inc. found a price floor2025 EndofYear Setup & Weekly Market Pulse Alerts - Newser
What’s the recovery path for long term holders of TherapeuticsMD Inc.Dollar Strength & Real-Time Buy Signal Alerts - Newser
What drives TherapeuticsMD Inc.’s stock priceJuly 2025 Gainers & Smart Swing Trading Alerts - khodrobank.com
When is the best time to exit TherapeuticsMD Inc.2025 Historical Comparison & Reliable Trade Execution Plans - Newser
Will TherapeuticsMD Inc. stock recover after recent dropDividend Hike & Safe Capital Growth Plans - Newser
Visual analytics tools that track TherapeuticsMD Inc. performanceEntry Point & Precise Buy Zone Identification - Newser
Long term hold vs stop loss in TherapeuticsMD Inc.July 2025 Fed Impact & High Conviction Investment Ideas - Newser
Will TherapeuticsMD Inc. outperform the marketWeekly Market Outlook & Verified Swing Trading Watchlists - Newser
Chart based exit strategy for TherapeuticsMD Inc.Trade Risk Assessment & Community Verified Trade Signals - Newser
How to escape a deep drawdown in TherapeuticsMD Inc.Weekly Profit Analysis & Expert Curated Trade Setup Alerts - Newser
TherapeuticsMD Inc. stock trend outlook and recovery pathMarket Activity Recap & Verified Entry Point Signals - Newser
Historical volatility pattern of TherapeuticsMD Inc. visualizedQuarterly Earnings Report & Real-Time Volume Trigger Notifications - Newser
Advanced analytics toolkit walkthrough for TherapeuticsMD Inc.Market Risk Summary & Daily Chart Pattern Signals - Newser
Identifying reversal signals in TherapeuticsMD Inc.CEO Change & Weekly Return Optimization Alerts - Newser
TherapeuticsMD Inc. Stock Underperforms Tuesday When Compared To Competitors - 富途牛牛
Will TherapeuticsMD Inc. continue its uptrendQuarterly Trade Report & Precise Swing Trade Alerts - Newser
Should value investors consider TherapeuticsMD Inc.2025 Risk Factors & Fast Gain Swing Alerts - خودرو بانک
Risk vs reward if holding onto TherapeuticsMD Inc.Quarterly Trade Summary & Weekly Chart Analysis and Trade Guides - Newser
Does TherapeuticsMD Inc. stock benefit from AI growthQuarterly Earnings Report & Free Community Consensus Stock Picks - khodrobank.com
Is TherapeuticsMD Inc. a candidate for recovery playJuly 2025 PreEarnings & Reliable Breakout Stock Forecasts - Newser
How to use Fibonacci retracement on TherapeuticsMD Inc.July 2025 Action & Precise Swing Trade Entry Alerts - Newser
Should you wait for a breakout in TherapeuticsMD Inc.July 2025 Technicals & Expert Curated Trade Setup Alerts - Newser
Nasdaq Moves: Does TherapeuticsMD Inc. stock benefit from AI growthMarket Activity Summary & Low Drawdown Investment Strategies - khodrobank.com
Screener Results Flag TherapeuticsMD Inc. as Oversold getLinesFromResByArray error: size == 0 - thegnnews.com
Is TherapeuticsMD Inc. part of any major indexEarnings Growth Summary & Technical Buy Zone Confirmation - khodrobank.com
What recovery options are there for TherapeuticsMD Inc.July 2025 Selloffs & Technical Entry and Exit Alerts - Newser
TherapeuticsMD Inc. stock trend forecastTrend Reversal & Reliable Trade Execution Plans - Newser
How to track smart money flows in TherapeuticsMD Inc.2025 Market Overview & Long-Term Growth Stock Strategies - Newser
Finanzdaten der Therapeuticsmd Inc-Aktie (TXMD)
Umsatz
Nettogewinn
Free Cashflow
ENV
Therapeuticsmd Inc-Aktie (TXMD) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
Walker Marlan D | Chief Executive Officer |
Apr 14 '25 |
Buy |
1.00 |
490 |
489 |
73,639 |
Walker Marlan D | Chief Executive Officer |
Apr 10 '25 |
Buy |
0.86 |
1,167 |
1,000 |
73,149 |
Walker Marlan D | Chief Executive Officer |
Apr 09 '25 |
Buy |
0.87 |
1,136 |
994 |
71,982 |
Collins Cooper C. | Director |
Feb 18 '25 |
Option Exercise |
0.00 |
8,500 |
0 |
60,516 |
Naughton Gail K | Director |
Feb 18 '25 |
Option Exercise |
0.00 |
8,500 |
0 |
8,500 |
Thompson Tommy G | Director |
Feb 18 '25 |
Option Exercise |
0.00 |
8,500 |
0 |
14,454 |
Walker Marlan D | Chief Executive Officer |
Feb 18 '25 |
Option Exercise |
0.00 |
8,281 |
0 |
70,846 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):